Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer. - Wikidata - awgldk - TriplyDB

Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.

Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.

http://www.wikidata.org/entity/Q37401837

about

Stem cells of the breast and cancer therapy.

P2860

Q37699356-4E76F050-BCEC-46AE-88EC-7B78A7ACF09B

P2860

Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.

http://www.wikidata.org/entity/Q37401837

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.

@en

Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.

@nl

type

label

Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.

@en

Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.

@nl

prefLabel

Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.

@en

Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.

@nl

P1433

Q37401837-325C7319-A770-40F0-94CF-7A21014B3E6B

P1476

Q37401837-E95CE466-EB40-4474-B0CC-CBB2D637AA16

P2093

Q37401837-3BCB6899-95A8-4F59-BECF-623643961F30

Q37401837-DBB8B01F-C22E-4066-A4CB-2307606D649E

P2860

Q37401837-0936317B-ACE4-4D2F-B7CB-4639BC73C473

Q37401837-1058FB4B-A986-4EBC-9448-91256447C701

Q37401837-137A64B3-B9EE-4137-BA6E-3D869356B46C

Q37401837-1D548C45-393B-4BB3-B2DB-2221A02B303D

Q37401837-1E4281A9-93D1-4ECD-A3B3-FD4F5DDAFEF7

Q37401837-22212314-878F-476F-B0EC-304117194723

Q37401837-276C5D40-A0FC-4527-AF19-9ACDAC06C140

Q37401837-28B6C8B8-0B6B-429A-ACD3-7A5C3ED1C9AB

Q37401837-29A0755B-6951-4FEF-8B84-15BC7F3D9C1D

Q37401837-3890871D-DE8D-4027-B112-D29F12387F82

P304

Q37401837-5D1E2431-3B4A-4B64-83AC-0A43587B286C

P31

Q37401837-437F6364-B359-4B33-9354-D289BE17CC47

P356

Q37401837-54061D5C-F8C2-49D0-90A5-0DDD96E3707C

P433

Q37401837-BBF79C2C-9E8F-4AD3-BEEC-D7EC05AB611D

P478

Q37401837-743B1C8A-C9B0-4685-9D72-0E61931ABDB2

P577

Q37401837-2E2B3391-DDF6-40D7-8332-ADAEA6B2CF8C

P698

Q37401837-AD68461B-1B23-4E3F-8A40-CE05AE292402

P356

17455057.5.2.135

P1433

P1476

Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.

@en

P2093

Bushra Haq

http://www.w3.org/2001/XMLSchema#string

Charles E Geyer

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Untangling the ErbB signalling network

Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Trastuzumab--mechanism of action and use in clinical practice

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

P304

135-147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/17455057.5.2.135

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19245352

http://www.w3.org/2001/XMLSchema#string